-
1دورية أكاديمية
المؤلفون: Lang JM; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI, USA., Kaikobad MR, Wallace M, Staab MJ, Horvath DL, Wilding G, Liu G, Eickhoff JC, McNeel DG, Malkovsky M
المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2011 Oct; Vol. 60 (10), pp. 1447-60. Date of Electronic Publication: 2011 Jun 07.
نوع المنشور: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carcinoma, Renal Cell/*therapy , Diphosphonates/*therapeutic use , Imidazoles/*therapeutic use , Interleukin-2/*therapeutic use , Kidney Neoplasms/*therapy , T-Lymphocytes/*transplantation, Adult ; Aged ; Cell Separation ; Female ; Flow Cytometry ; Humans ; Immunotherapy/methods ; Lymphocyte Activation/drug effects ; Lymphocyte Activation/immunology ; Male ; Middle Aged ; Pilot Projects ; Receptors, Antigen, T-Cell, gamma-delta/immunology ; T-Lymphocytes/immunology ; Zoledronic Acid
-
2دورية أكاديمية
المؤلفون: Hotton KM; Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA., Khorsand M, Hank JA, Albertini M, Kim KM, Wilding G, Salamat MS, Larson M, Sondel P, Schiller JH
المصدر: Cancer [Cancer] 2000 Apr 15; Vol. 88 (8), pp. 1892-901.
نوع المنشور: Case Reports; Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell/*drug therapy , Carcinoma, Renal Cell/*secondary , Granulocyte-Macrophage Colony-Stimulating Factor/*administration & dosage , Interleukin-2/*administration & dosage , Kidney Neoplasms/*drug therapy , Kidney Neoplasms/*pathology , Lung Neoplasms/*drug therapy , Lung Neoplasms/*secondary, Adult ; Aged ; Cerebral Hemorrhage/chemically induced ; Drug Administration Schedule ; Drug Therapy, Combination ; Fatal Outcome ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects ; Humans ; Interleukin-2/adverse effects ; Intracranial Thrombosis/chemically induced ; Male ; Middle Aged ; Nervous System/drug effects ; Treatment Outcome ; Venous Thrombosis/chemically induced
-
3دورية أكاديمية
المؤلفون: Schiller JH; University of Wisconsin Comprehensive Cancer Center, Departments of Human Oncology and Medicine, Madison, Wisconsin 53792, USA., Hank JA, Khorsand M, Storer B, Borchert A, Huseby-Moore K, Burns D, Wesly O, Albertini MR, Wilding G, Sondel PM
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 1996 Feb; Vol. 2 (2), pp. 319-30.
نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Granulocyte-Macrophage Colony-Stimulating Factor/*administration & dosage , Interleukin-2/*administration & dosage , Neoplasms/*therapy, Adult ; Aged ; Antibody-Dependent Cell Cytotoxicity ; CD56 Antigen/analysis ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects ; HLA-DR Antigens/analysis ; Humans ; Interleukin-2/adverse effects ; Killer Cells, Lymphokine-Activated/immunology ; Male ; Middle Aged ; Neoplasms/immunology ; Receptors, IgG/analysis ; Receptors, Interleukin-2/analysis
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.